Your browser doesn't support javascript.
loading
Outpatient High-dose Methotrexate for Osteosarcoma: It's Safe and Feasible, If You Want It.
Hendershot, Eleanor; Volpe, Jocelyn; Taylor, Tracey; Nicksy, Darcy; Mills, Denise; Ramachandran, Nivetha; Shaikh, Furqan; Riss, Vera; Grant, Ronald; Gupta, Abha A.
Afiliação
  • Hendershot E; Division of Hematology/Oncology, McMaster Children's Hospital.
  • Volpe J; Division of Hematology/Oncology, Hospital for Sick Children.
  • Taylor T; Division of Hematology/Oncology, Hospital for Sick Children.
  • Nicksy D; Department of Pharmacy, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
  • Mills D; Department of Pharmacy, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
  • Ramachandran N; Division of Hematology/Oncology, Hospital for Sick Children.
  • Shaikh F; Division of Hematology/Oncology, Hospital for Sick Children.
  • Riss V; Division of Hematology/Oncology, Hospital for Sick Children.
  • Grant R; Department of Pharmacy, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
  • Gupta AA; Division of Hematology/Oncology, Hospital for Sick Children.
J Pediatr Hematol Oncol ; 41(5): 394-398, 2019 07.
Article em En | MEDLINE | ID: mdl-29965827

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pacientes Ambulatoriais / Osteossarcoma / Metotrexato Tipo de estudo: Observational_studies Limite: Adolescent / Humans Idioma: En Revista: J Pediatr Hematol Oncol Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pacientes Ambulatoriais / Osteossarcoma / Metotrexato Tipo de estudo: Observational_studies Limite: Adolescent / Humans Idioma: En Revista: J Pediatr Hematol Oncol Ano de publicação: 2019 Tipo de documento: Article